🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 4 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/11/2002 27,90 28,62 27,42 27,60 -3,36% 4,30% 12.517
14/11/2002 29,22 29,40 27,54 28,56 -3,45% 6,37% 14.483
13/11/2002 29,46 30,30 27,00 29,58 -0,40% 11,20% 12.250
12/11/2002 30,72 30,84 28,92 29,70 -1,98% 6,25% 10.400
11/11/2002 30,84 32,82 30,12 30,30 -1,75% 8,75% 8.533
08/11/2002 30,54 30,84 30,30 30,84 +0,39% 1,77% 6.500
07/11/2002 31,44 32,10 30,42 30,72 -3,03% 5,34% 22.500
06/11/2002 31,62 31,80 30,90 31,68 +0,76% 2,85% 18.117
05/11/2002 28,38 31,50 28,32 31,44 +2,75% 11,21% 17.183
04/11/2002 32,10 32,40 30,12 30,60 -2,86% 7,10% 10.317
01/11/2002 30,72 32,10 30,30 31,50 +1,35% 5,86% 7.917
31/10/2002 31,20 31,20 30,30 31,08 +0,00% 2,88% 6.183
30/10/2002 30,66 31,80 30,60 31,08 +1,57% 3,91% 11.917
29/10/2002 32,40 33,00 29,10 30,60 -5,38% 12,04% 25.833
28/10/2002 32,88 33,30 32,10 32,34 +0,75% 3,65% 19.400
25/10/2002 30,48 32,10 29,88 32,10 +7,65% 7,28% 27.417
24/10/2002 30,06 30,60 29,10 29,82 -0,60% 4,99% 21.833
23/10/2002 28,20 30,00 28,20 30,00 +5,04% 6,38% 12.600
22/10/2002 28,80 29,22 27,30 28,56 -0,83% 6,67% 9.450
21/10/2002 28,50 29,34 27,72 28,80 +1,27% 5,68% 10.117
18/10/2002 28,20 28,80 27,12 28,44 +0,42% 5,96% 9.517
17/10/2002 29,28 29,70 27,66 28,32 -1,67% 6,97% 8.667
16/10/2002 28,74 29,34 28,20 28,80 +0,42% 3,97% 6.350
15/10/2002 29,70 31,02 27,90 28,68 -2,25% 10,51% 20.983
14/10/2002 29,40 29,82 28,50 29,34 +0,62% 4,49% 6.050
11/10/2002 30,30 30,60 28,74 29,16 -2,41% 6,14% 6.917
10/10/2002 29,40 29,94 27,00 29,88 -0,99% 10,00% 14.033
09/10/2002 31,50 31,56 29,70 30,18 -5,09% 5,90% 14.400
08/10/2002 32,10 33,00 30,06 31,80 -3,46% 9,16% 12.783
07/10/2002 32,40 33,30 31,50 32,94 +0,37% 5,56% 11.167